JOM KITA KE POLITEKNIK

LC-MS/MS based detection of circulating proinsulin derived peptides in patients with altered pancreatic beta cell function (Record no. 513)

MARC details
042 ## - AUTHENTICATION CODE
Authentication code dc
100 10 - MAIN ENTRY--PERSONAL NAME
Personal name Foreman, Rachel E
Relator term author
9 (RLIN) 3116
245 00 - TITLE STATEMENT
Title LC-MS/MS based detection of circulating proinsulin derived peptides in patients with altered pancreatic beta cell function
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2022-11-15.
500 ## - GENERAL NOTE
General note /pmc/articles/PMC7614196/
500 ## - GENERAL NOTE
General note /pubmed/36242807
520 ## - SUMMARY, ETC.
Summary, etc. Routine immunoassays for insulin and C-peptide have the potential to cross-react with partially processed proinsulin products, although in healthy patients these are present at such low levels that the interference is insignificant. Elevated concentrations of proinsulin and des-31,32 proinsulin arising from pathological conditions, or injected insulin analogues, however can cause significant assay interferences, complicating interpretation. Clinical diagnosis and management therefore sometimes require methods that can distinguish true insulin and C-peptide from partially processed proinsulin or injected insulin analogues. In this scenario, the high specificity of mass spectrometric analysis offers potential benefit for patient care. A high throughput targeted LC-MS/MS method was developed as a fit for purpose investigation of insulin, insulin analogues, C-peptide and proinsulin processing intermediates in plasma samples from different patient groups. Using calibration standards and bovine insulin as an internal standard, absolute concentrations of insulin and C-peptide were quantified across a nominal human plasma postprandial range and correlated strongly with immunoassay-based measurements. The ability to distinguish between insulin, insulin analogues and proinsulin intermediates in a single extraction is an improvement over existing immunological based techniques, offering the advantage of exact identification of the species being measured. The method promises to aid in the detection of circulating peptides which have previously been overlooked but may interfere with standard insulin and C-peptide immunoassays.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction https://creativecommons.org/licenses/by/4.0/This work is licensed under a CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) International license.
546 ## - LANGUAGE NOTE
Language note en
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element Article
655 7# - INDEX TERM--GENRE/FORM
Genre/form data or focus term Text
Source of term local
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Meek, Claire L
Relator term author
9 (RLIN) 3117
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Roberts, Geoffrey P
Relator term author
9 (RLIN) 3118
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name George, Amy L
Relator term author
9 (RLIN) 3119
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Reimann, Frank
Relator term author
9 (RLIN) 3120
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Gribble, Fiona M
Relator term author
9 (RLIN) 3121
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Kay, Richard G
Relator term author
9 (RLIN) 3122
786 0# - DATA SOURCE ENTRY
Note J Chromatogr B Analyt Technol Biomed Life Sci
856 41 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1016/j.jchromb.2022.123482">http://dx.doi.org/10.1016/j.jchromb.2022.123482</a>
Public note Connect to this object online.

No items available.